Free tool
FAERS Monitor: Valium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 013263 or its brand name (Valium, Diazepam). Reports on generic versions are filed under their own applications.
Reports
122,026
Serious
99,147
81% of reports
Hospitalization
42,335
Death reported
23,313
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxicity to various agents9,867
- drug abuse7,278
- drug ineffective7,261
- nausea6,339
- fatigue5,823
- pain5,297
- anxiety5,105
- somnolence5,104
- headache5,090
- off label use4,802
- dizziness4,588
- vomiting4,534
- dyspnoea4,440
- drug interaction4,382
- fall4,323
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,847 |
| 2005 | 2,190 |
| 2006 | 1,948 |
| 2007 | 2,018 |
| 2008 | 2,664 |
| 2009 | 2,807 |
| 2010 | 3,815 |
| 2011 | 4,069 |
| 2012 | 4,881 |
| 2013 | 5,162 |
| 2014 | 5,458 |
| 2015 | 7,240 |
| 2016 | 7,839 |
| 2017 | 8,052 |
| 2018 | 8,633 |
| 2019 | 9,208 |
| 2020 | 8,609 |
| 2021 | 6,932 |
| 2022 | 6,023 |
| 2023 | 5,850 |
| 2024 | 6,079 |
| 2025 | 6,122 |
| 2026 | 4,566 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,932,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug abuseSignal | 7,278 | 16.4 | 16.0 | 96,533 |
| toxicity to various agentsSignal | 9,867 | 10.6 | 10.4 | 81,871 |
| drug interactionSignal | 4,382 | 4.9 | 4.7 | 13,191 |
| somnolenceSignal | 5,104 | 4.5 | 4.3 | 13,463 |
| anxietySignal | 5,105 | 3.1 | 3.0 | 7,365 |
| fallSignal | 4,323 | 2.3 | 2.2 | 3,027 |
| vomiting | 4,534 | 1.7 | 1.6 | 1,230 |
| dizziness | 4,588 | 1.6 | 1.5 | 1,021 |
| pain | 5,297 | 1.5 | 1.5 | 873 |
| headache | 5,090 | 1.4 | 1.4 | 601 |
| nausea | 6,339 | 1.4 | 1.4 | 694 |
| dyspnoea | 4,440 | 1.4 | 1.3 | 420 |
| fatigue | 5,823 | 1.3 | 1.3 | 394 |
| drug ineffective | 7,261 | 0.9 | 0.9 | 21 |
| off label use | 4,802 | 0.9 | 0.9 | 16 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.